Yesha Sivan’s Post

"Eyes on the Prize: Takeda's Latest Pivot🔄💡 In an industry where agility is king, Takeda's bold move to streamline and sharpen its focus is a play we should all watch closely. With patents expiring and the financial landscape shifting, Takeda is cutting the chaff to reveal the wheat—one well-organized workforce and a leaner pipeline geared towards profitability. Their latest fiscal year report isn't just numbers—it's a strategy unveiling. Think trimming R&D while amplifying late-stage assets with the potential to be heavy hitters in the sales department. But it's not just about cuts—it's strategic reinvestment. Data, digital, and tech aren't just buzzwords; they're the fertile ground Takeda is betting on. Meanwhile, external spending is on the chopping block, sharpening Takeda's competitive edge. The message to decision-makers and tech trailblazers in MedTech and biopharma? Adaptability and precision are your best allies. Whether in the boardroom or the lab, turning challenges into growth opportunities is what sets industry leaders apart. Let's talk about how this level of strategic fine-tuning can elevate your game to the next level.📈 #Pharmaceuticals #Innovation #BusinessStrategy"

📈 Exploring the digital frontier in pharma: AZ's winning strategy! 💻💡 Discover how digital marketing can increase brand ROI while creating meaningful consumer experiences. What does it take for AstraZeneca to be a leader in this space? Join the conversation at the IXL Center's Innovation Olympics Challenge! 🏆🌐 Learn more at https://lnkd.in/eN2w8rf 🔍 #DigitalPharma #IXLOlympics 🚀

💡3 Insightful tips for Launch Excellence in 30 seconds? Swipe through the latest DIARY OF AN INVESTOR entry below with Pamela Walker Geddes and Catarina Santos PhD, MBA from Novartis on this all-important #pharma topic!

Best quote to wrap up a presentation about digital journeys..."Keep Moving Forward. " - Walt Disney Come join me at Innovate Pharma Healthcare 2023 to hear all about changing industry mindset from Digital Transformation to a Digital Journey!

Getting outside-in perspective from people who say it as they see it, can make a significant difference to an organization's future (and the share price)! Clarity of thought in an organization can often get blurred by short-term goals/biases/organizational politics etc. If you are the CEO of any organization, this is a great tool-kit in your toolbox. Great share Karthik Srinivasan. Fantastic move by Vas Narasimhan!

Be it in the Land of the Rising Sun or the Land of Opportunities, I saw yet again that colleagues at Boehringer Ingelheim are ONE in patient focus - in every plan and initiative. Over the past few weeks, I had the opportunity to visit colleagues and teams in the US and Japan. I am personally filled with so much learning and experiences that I am grateful to the colleagues that made these visits and meetings meaningful. My colleagues and I return enriched by the vibrant discussions, solution orientation and openness to feedback and sharing.     Of all the experiences, there is one that stands out – the power of direct exchange. At the root of every success story was a discussion and a thirst to learn, understand and continuously educate ourselves. That these discussions were centered around holistic care for patients from screening, diagnosis, treatment and prognosis / care was most heartening! In the US, I saw strong collaboration between teams and deep insight into patient perspectives, as they navigate complex and ever-changing healthcare environments. In Japan, I was humbled by the level of partnership, collaboration and commitment that colleagues brought to their work every day. Both teams, in their open and direct exchange are focusing on delivering healthcare accessibility and needs-based treatment. I believe that continuing with such direct exchange with help us bring together insights from across the world on clinical trials, research and public-private partnerships, thus enabling us to harness the power of science and innovation across borders, to deliver value for patients. #Cooperation #Partnerships #PatientCentricity #DirectExchange 

ZS conducts Impact Live/Summit event every year, and this year we were lucky to resume a face-to-face event in not one but 3 locations! Here were my personal notes on my topic of interest mainly around Pharma-HCP engagement model: - The what - reps need to be more consultative and less transactional - this is already the case for only 20-30% of good reps, but today we have technology that helps 80% of reps be good reps. - The how - facilitating better connection between marketing and sales (and by extension Medical Affairs in a compliant way) so that pharma works as as a team to solve HCP's issues. The thread that holds them together is metrics that each function can agree to. Enterprise data sharing becomes key. Also, from my experience, a healthy people exchange - e.g. reps working in HQ Medical and marketers working in the field, and IT Directors serving as Sales Directors really helps break down these silos and fosters a culture of cross-functional collaboration. I hope to see more of that. --- #Pharma faces new challenges from evolving market forces. At ZS's #ImpactLive events, we focused on ideas and technologies companies can explore to either adapt and thrive or ignore and risk extinction. #AI #DrugDiscovery

Is pharma ready to transform and unlock the value of precision medicines and personalized treatments?   At Axtria's Commercial Excellence Summit, global pharma leaders converged to discuss the challenges and shared eight key insights on strategy, organization, and investment for a future-ready industry.   ⬇️Download this report to learn more about the key takeaways from this esteemed group, including: ✔️How to change frontline teams to meet the needs of personalized medicine ✔️How to make marketing campaigns and execution strategies more precise and targeted ✔️How to integrate data and technology across functions ✔️How to focus on patients and their evolving needs ✔️How to manage costs effectively and be more agile   Download the complete report here: https://lnkd.in/e6BkZSWF   #CommercialPharma #Lifesciences #CESummit Jaswinder Chadha Amanjeet Saluja

ROI can be easy to calculate, or it can be social 🤣 When Mark Bard of The DHC Group sat down with Jemeleth "Milet" K. of Genentech, she said, "Social will have ROI, but it takes time for us to develop, and unpack that." Check out her insight on the importance of social media and how to measure Social ROI... Watch Here: https://lnkd.in/ec_96qUW